The Japan artificial organs bionic implants market size was USD XX Billion in 2022 and is likely to reach USD XX Billion by 2031, expanding at a CAGR of 7.5% during 2023–2031. The growth of the market is attributed to organ failure is more common among the elderly or age-related ailments, which drives the market growth.
Artificial organs and bionic implants are developed medical devices that can be worn on the outside or implanted. Artificial organs are inserted into the body to replace the original organs if the original organ fails and if any organ is destroyed by an external event, such as an accident. Severe blood loss, drug addiction, significant trauma, and other acute disorders are among the most common causes of organ failure. Furthermore, unhealthy lifestyles including poor eating habits, smoking, drinking too much alcohol, and not exercising enough are also major causes of organ failure.
Implantable devices with electrical and mechanical components are referred to as bionic implants. They can be divided into two categories: electronics and biological. Additionally, they are upgraded robotic technologies. Biomaterials, which are manmade substances that connect with biological processes utilized for medical purposes, are used to make artificial organs and bionic implants.
Japan Artificial Organs Bionic Implants Market Trends, Drivers, Restraints, and Opportunities
-
Several vehicle accidents, injuries, and consequent disabilities are projected to propel the market growth in the coming years.
-
Rising significantly number of patients waiting for organ transplants is a key factor spurring the market expansion during the forecast period.
-
High price of machines and systems, as well as the threat of compatibility problems and failures, is estimated to impede the market growth.
-
Increasing technological advances and increased government support are anticipated to create immense opportunities for the market players.
Scope of Japan Artificial Organs Bionic Implants Market Report
The report on the Japan artificial organs bionic implants market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Japan Artificial Organs Bionic Implants Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2022
|
|
Historic Data
|
2016–2021
|
|
Forecast Period
|
2023–2031
|
|
Segmentation
|
Types (Bionics [Cardiac Bionics, Orthopedic Bionics, Vision Bionics, and Others] and Artificial Organs [Cochlear Implants, Artificial Lungs, Artificial Kidneys, Artificial Hearts, and Others]), Methods of Fixation (Externally Worn and Implantable), Technology (Electronic and Mechanical), and Applications (Clinical Research Institutions, Hospitals, and Others)
|
|
Country
|
Japan
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Ossur; Medtronic; Getinge AB.; Cyberonics, Inc.; Cochlear Ltd.; Boston Scientific Corporation; Berlin Heart ; Baxter.; Asahi Kasei Medical Co., Ltd.; and ABIOMED.
|
Japan Artificial Organs Bionic Implants Market Segment Insights
Artificial Hearts segment is projected to hold a large market share
Based on types, the Japan artificial organs bionic implants market is segregated into bionics and artificial organs. The bionics segment is further divided into cardiac bionics, orthopedic bionics, vision bionics, and others. The artificial organs segment is further segmented into cochlear implants, artificial lungs, artificial kidneys, artificial hearts, and others. The artificial hearts by artificial organs segment is expected to constitute a key share of the market in the coming years due to a survey, Japan has the greatest percentage of people over the age of 60, having 30% of the population falling into this category.
Furthermore, the survey predicts that by 2050, this group would account for 40% of the population. Cardiovascular disease, kidney disease, and neurological issues are just a few of the chronic illnesses that the senior population is prone to. The risk of developing organ failure increases dramatically as one gets older. As a result, Japan's aging population is responsible for driving growth in the artificial organs and bionics market during the forecast period.
Externally worn segment is anticipated to expand at a rapid CAGR
In terms of methods of fixation, the market is segmented into externally worn and implantable. The externally worn segment is expected to represent a key share of the market in the coming years due to growth can be ascribed to the introduction of new upgraded gadgets that are coupled with technological benefits as technology advances.
Mechanical segment is projected to represent a major market share
Based on technology, the Japan artificial organs bionic implants market is bifurcated into electronic and mechanical. The mechanical segment is expected to hold a key share of the market during the forecast period owing to the mechanical artificial heart valves survive significantly longer than conventional choices, resulting in high demand. Fast FDA clearances and reimbursements are also aiding the growth.
Hospital’s segment is expected to register at a significant pace
On the basis of applications, the market is divided into clinical research institutions, hospitals, and others. The hospital’s segment is expected to account for a key share of the market during the forecast period owing to the presence of modern healthcare infrastructure and trained physicians improve procedural adoption rates in the hospitals. The availability of the latest technology in hospitals is driving the growth of the market segment.
Segments
The Japan artificial organs bionic implants market has been segmented based on
Types
- Bionics
- Cardiac Bionics
- Orthopedic Bionics
- Vision Bionics
- Others
- Artificial Organs
- Cochlear Implants
- Artificial Lungs
- Artificial Kidneys
- Artificial Hearts
- Others
Methods of Fixation
- Externally Worn
- Implantable
Technology
Applications
- Clinical Research Institutions
- Hospitals
- Others
Key Players
- Ossur
- Medtronic
- Getinge AB.
- Cyberonics, Inc.
- Cochlear Ltd.
- Boston Scientific Corporation
- Berlin Heart
- Baxter.
- Asahi Kasei Medical Co., Ltd.
- ABIOMED
Competitive Landscape
Key players competing in the Japan artificial organs bionic implants market are Ossur; Medtronic; Getinge AB.; Cyberonics, Inc.; Cochlear Ltd.; Boston Scientific Corporation; Berlin Heart Baxter.; Asahi Kasei Medical Co., Ltd.; and ABIOMED. Some of these players are adopting several business strategies such as acquisitions, mergers, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares.
Request For Customization
Enquiry Before Buying
Speak With Analyst
